No Data
Express News | BioLineRx Outlines Vision For 2025: Plans New Oncology/Rare Disease In-Licensing, 1-For-40 Reverse Stock Split To Meet Nasdaq Compliance, $29.5M Cash, Runway Through H2 2026
Express News | BioLine RX Ltd: Current Cash Runway to Execute Upon Goals Through H2 2026
BioLineRx Reports Change To Ratio Of American Depositary Shares To Ordinary Shares; Change In Exchange Ratio To Have Same Effect As 1-For-40 Reverse Stock Split
12 Health Care Stocks Moving In Monday's Pre-Market Session
US Stocks Open Higher; Dow Jumps Over 200 Points
BioLineRx Announces $10M Registered Direct Offering Of 50M American Depositary Shares And Accompanying Warrants To Purchase Up To An Aggregate Of 50M ADSs, At A Purchase Price Of $0.20 Per ADS
EUGENE啊梁 : On the 30th, it dropped to the point where even your mom wouldn't recognize it.
Lnova : Is why I buy long calls on it for end of summer
NoobInvestor : Biggest copium inhaler on moomoo browny
browny_440 OP : ONVO